This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 10 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.2357 per ML under NDC 00641036725. Its NADAC has been published 247 times since Mar 19, 2014.
FDA first approved this application on Sep 7, 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641036725
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA087702FDA Approved
9/7/1982
TE Code
AP
On Market Since
9/7/1982
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 10 MG/ML VIAL has been published 247 times since Mar 19, 2014, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2357 per ML |
|---|---|
| All-time high | $1.3445 (Jun 15, 2016) |
| All-time low | $1.1447 (Nov 19, 2014) |
| 52-week high | $1.2472 |
| 52-week low | $1.1842 |
| Median price | $1.2357 |
| Average price | $1.2459 |
| Largest weekly change | -11.5% (Apr 17, 2024) |
| Weeks tracked | 247 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone Sodium Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 10 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 10 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.2357 per ML (NDC 00641036725), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 10 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 10 MG/ML VIAL has declined 5.4%. It has been tracked across 247 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 10 MG/ML VIAL?
Since Mar 19, 2014, the NADAC for DEXAMETHASONE 10 MG/ML VIAL has ranged from a low of $1.1447 (Nov 19, 2014) to a high of $1.3445 (Jun 15, 2016), with a median of $1.2357 per ML.
Are there cheaper alternatives to DEXAMETHASONE 10 MG/ML VIAL?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 100 MG/10 ML VL, is $0.5104 per ML — about 59% below DEXAMETHASONE 10 MG/ML VIAL.
Who manufactures DEXAMETHASONE 10 MG/ML VIAL?
DEXAMETHASONE 10 MG/ML VIAL (NDC 00641036725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is DEXAMETHASONE 10 MG/ML VIAL in shortage?
Yes — NDC 00641036725 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).